Cargando…

MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance

SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinico...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilczynski, Milosz, Kielbik, Michal, Senderowska, Daria, Krawczyk, Tomasz, Szymanska, Bozena, Klink, Magdalena, Bieńkiewicz, Jan, Romanowicz, Hanna, Frühauf, Filip, Malinowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563310/
https://www.ncbi.nlm.nih.gov/pubmed/32961797
http://dx.doi.org/10.3390/cancers12092680
_version_ 1783595462537773056
author Wilczynski, Milosz
Kielbik, Michal
Senderowska, Daria
Krawczyk, Tomasz
Szymanska, Bozena
Klink, Magdalena
Bieńkiewicz, Jan
Romanowicz, Hanna
Frühauf, Filip
Malinowski, Andrzej
author_facet Wilczynski, Milosz
Kielbik, Michal
Senderowska, Daria
Krawczyk, Tomasz
Szymanska, Bozena
Klink, Magdalena
Bieńkiewicz, Jan
Romanowicz, Hanna
Frühauf, Filip
Malinowski, Andrzej
author_sort Wilczynski, Milosz
collection PubMed
description SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinicopathological data. MiRNA-103/107, DICER expression levels were also evaluated in selected ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. However, the results of our study support the possible existence of miRNA-103/107- DICER axis in ovarian cancer. ABSTRACT: High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression levels have never been related to patients’ clinicopathological data in epithelial ovarian cancer. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues. Expression levels of both miRNAs were related to the clinicopathological features and survival. We also evaluated expression levels of miRNA-103/107 and DICER in selected ovarian cancer cell lines (A2780, A2780cis, SK-OV-3, OVCAR3). We assessed the relative expression of miRNA-103/107 (quantitative reverse transcription-polymerase chain reaction) in fifty archival formalin-fixed paraffin-embedded tissue samples of primary high grade serous ovarian cancer. Then, miRNA-103/107 and DICER expression levels were evaluated in selected ovarian cancer cell lines. Additionally, DICER, N-/E-cadherin protein levels were assessed with the use of western blot. We identified miRNA-107 up-regulation in ovarian cancer in comparison to healthy tissues (p = 0.0005). In the case of miRNA-103, we did not observe statistically significant differences between cancerous and healthy tissues (p = 0.07). We did not find any correlations between miRNA-103/107 expression levels and clinicopathological features. Kaplan–Meier survival (disease-free and overall survival) analysis revealed that both miRNAs could not be considered as prognostic factors. SK-OV-3 cancer cell lines were characterized by high expression of miRNA-103/107, relatively low expression of DICER (western-blot), and relatively high N-cadherin levels in comparison to other ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study.
format Online
Article
Text
id pubmed-7563310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75633102020-10-27 MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance Wilczynski, Milosz Kielbik, Michal Senderowska, Daria Krawczyk, Tomasz Szymanska, Bozena Klink, Magdalena Bieńkiewicz, Jan Romanowicz, Hanna Frühauf, Filip Malinowski, Andrzej Cancers (Basel) Article SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinicopathological data. MiRNA-103/107, DICER expression levels were also evaluated in selected ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. However, the results of our study support the possible existence of miRNA-103/107- DICER axis in ovarian cancer. ABSTRACT: High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression levels have never been related to patients’ clinicopathological data in epithelial ovarian cancer. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues. Expression levels of both miRNAs were related to the clinicopathological features and survival. We also evaluated expression levels of miRNA-103/107 and DICER in selected ovarian cancer cell lines (A2780, A2780cis, SK-OV-3, OVCAR3). We assessed the relative expression of miRNA-103/107 (quantitative reverse transcription-polymerase chain reaction) in fifty archival formalin-fixed paraffin-embedded tissue samples of primary high grade serous ovarian cancer. Then, miRNA-103/107 and DICER expression levels were evaluated in selected ovarian cancer cell lines. Additionally, DICER, N-/E-cadherin protein levels were assessed with the use of western blot. We identified miRNA-107 up-regulation in ovarian cancer in comparison to healthy tissues (p = 0.0005). In the case of miRNA-103, we did not observe statistically significant differences between cancerous and healthy tissues (p = 0.07). We did not find any correlations between miRNA-103/107 expression levels and clinicopathological features. Kaplan–Meier survival (disease-free and overall survival) analysis revealed that both miRNAs could not be considered as prognostic factors. SK-OV-3 cancer cell lines were characterized by high expression of miRNA-103/107, relatively low expression of DICER (western-blot), and relatively high N-cadherin levels in comparison to other ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. MDPI 2020-09-19 /pmc/articles/PMC7563310/ /pubmed/32961797 http://dx.doi.org/10.3390/cancers12092680 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wilczynski, Milosz
Kielbik, Michal
Senderowska, Daria
Krawczyk, Tomasz
Szymanska, Bozena
Klink, Magdalena
Bieńkiewicz, Jan
Romanowicz, Hanna
Frühauf, Filip
Malinowski, Andrzej
MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title_full MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title_fullStr MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title_full_unstemmed MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title_short MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
title_sort mirna-103/107 in primary high-grade serous ovarian cancer and its clinical significance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563310/
https://www.ncbi.nlm.nih.gov/pubmed/32961797
http://dx.doi.org/10.3390/cancers12092680
work_keys_str_mv AT wilczynskimilosz mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT kielbikmichal mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT senderowskadaria mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT krawczyktomasz mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT szymanskabozena mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT klinkmagdalena mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT bienkiewiczjan mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT romanowiczhanna mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT fruhauffilip mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance
AT malinowskiandrzej mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance